Sugi Predict

Sugi Predict / Compounds / SCHEMBL18646799

SCHEMBL18646799

SCHEMBL18646799

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4nc5c(ccc6c7ccccc7sc65)c5ccccc45)cc3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ ATM Q13315 2/20 0.43
▸ TNKS O95271 3/20 0.36
▸ TNKS2 Q9H2K2 3/20 0.36
▸ ALOX5 P09917 1/20 0.35
▸ MAPT P10636 3/20 0.35
▸ GPR3 P46089 1/20 0.34
▸ LIMK1 P53667 3/20 0.33
▸ GAA P10253 2/20 0.33
▸ L3MBTL1 Q9Y468 2/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ WHR1 P49842 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CDK5 Q00535 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18646811 0.93 TNKS (0.36) MEN1KMT2AATMTNKSTNKS2
SCHEMBL22225629 0.92 MEN1 (0.41) MEN1KMT2AATMTNKSTNKS2
SCHEMBL22273920 0.91 MEN1 (0.41) MEN1KMT2AATMTNKSTNKS2
SCHEMBL18646801 0.91 TNKS (0.36) MEN1KMT2AATMTNKSTNKS2
SCHEMBL22273906 0.90 LIMK1 (0.41) MEN1KMT2AATMTNKSTNKS2
SCHEMBL19758411 0.88 MEN1 (0.44) MEN1KMT2AATMTNKSTNKS2
SCHEMBL19758394 0.87 MEN1 (0.43) MEN1KMT2AATMTNKSTNKS2
SCHEMBL24280710 0.87 ALOX5 (0.43) MEN1KMT2AATMTNKSTNKS2
SCHEMBL22274171 0.87 ALOX5 (0.46) MEN1KMT2AATMTNKSTNKS2
SCHEMBL24280858 0.86 ALOX5 (0.42) MEN1KMT2AATMTNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10968208-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2021-04-06 — — US disclosed
US-20200223835-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2020-07-16 — — US disclosed
WO-2017043797-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2017-03-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10968208-B2 Compound for organic electronic element, organic electronic element comprising the same, and electronic device thereof PIEZO1, OCIAD1, EML4 MEN1 891/4885KMT2A 964/4885ATM 4354/4885
US-20200223835-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, EML4 MEN1 891/4885KMT2A 964/4885ATM 4354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback